Oxaliplatin and Uveitis - a phase IV clinical study of FDA data

Summary:

Uveitis is reported as a side effect among people who take Oxaliplatin (oxaliplatin), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Fluorouracil, and have Colorectal cancer metastatic.

The phase IV clinical study analyzes which people have Uveitis when taking Oxaliplatin. It is created by eHealthMe based on reports of 71,972 people who have side effects when taking Oxaliplatin from the FDA, and is updated regularly.

What is Oxaliplatin?

Oxaliplatin has active ingredients of oxaliplatin. It is often used in colon cancer. eHealthMe is studying from 72,058 Oxaliplatin users. Check the latest studies of Oxaliplatin.

What is Uveitis?

Uveitis (inflammation of the uvea) is found to be associated with 831 drugs and 1,528 conditions by eHealthMe. Check the latest studies of Uveitis.

On Jul, 13, 2026

71,972 people reported to have side effects when taking Oxaliplatin.
Among them, 17 people (0.02%) have Uveitis.

Among these 17 people:

How long have people been on Oxaliplatin when they have Uveitis? *

What is the gender of people who have Uveitis when taking Oxaliplatin? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Uveitis when taking Oxaliplatin? *

What are other drugs people take besides Oxaliplatin? *

Fluorouracil: 11 people, 64.71%
Capecitabine: 8 people, 47.06%
Magnesium Oxide: 5 people, 29.41%
Avastin: 3 people, 17.65%
Erbitux: 3 people, 17.65%
Irinotecan Hydrochloride: 3 people, 17.65%
Vectibix: 3 people, 17.65%
Dexamethasone Sodium Phosphate: 3 people, 17.65%
Decadron: 3 people, 17.65%
Fosaprepitant: 3 people, 17.65%

What are other side effects people have besides Uveitis? *

Fever: 6 people, 35.29%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 29.41%
Infection: 4 people, 23.53%
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 4 people, 23.53%
Blindness Unilateral: 4 people, 23.53%
Cerebral Atrophy (decrement in size of brain): 4 people, 23.53%
Coronary Artery Thrombosis (clot formation in coronary artery): 4 people, 23.53%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 4 people, 23.53%
Liver Disorder (liver diseases): 4 people, 23.53%
Pulmonary Infarction (death of a small area of lung): 4 people, 23.53%

What are the existing conditions these people have? *

Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 4 people, 23.53%
Gastric Cancer (stomach cancer): 3 people, 17.65%
Cachexia (loss of weight): 3 people, 17.65%
Small Intestine Carcinoma (cancer tumour of small intestine): 2 people, 11.76%
Gastroesophageal Cancer: 2 people, 11.76%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 2 people, 11.76%
Malignant Anorectal Neoplasm (cancerous tumour of anus or rectum): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Oxaliplatin and have Uveitis?

- Check whether Uveitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxaliplatin:

Oxaliplatin (72,058 reports)

Uveitis treatments and more:

Uveitis (29,545 reports)

Browse all side effects of Oxaliplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Uveitis:

Uveitis (831 drugs)

Browse all the conditions that are associated with Uveitis:

Uveitis (1,528 conditions)

Related publications that referenced our studies

Kim HJ, An SH, Cho YH, Kim SY, Lee HG, Yoon SY, "Oxaliplatin-induced Torsades de pointes and long QT syndrome in a patient with gastric cancer", Acta Oncologica, 2013 Aug .
Wang JH, King TM, Chang MC, Hsu CW, "Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis", World journal of gastroenterology: WJG, 2012 Oct .
Kim HJ, An SH, Cho YH, Kim SY, Lee HG, Yoon SY, "Oxaliplatin-induced Torsades de pointes and long QT syndrome in a patient with gastric cancer", Acta Oncologica, 2013 Aug .
Wang JH, King TM, Chang MC, Hsu CW, "Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis", World journal of gastroenterology: WJG, 2012 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on oxaliplatin (the active ingredients of Oxaliplatin) and Oxaliplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.